Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Enavate Sciences
AddedFeb 13, 2024
UpdatedJul 16, 2026
Enavate Sciences

Enavate Sciences

Private Equity

Enavate Sciences: Investing in and fostering growth of innovative therapeutic tech firms.

HQ
New York City, NY, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to transform patient care, Enavate Sciences is an investment platform dedicated to supporting the strategic growth of innovative therapeutic and enabling technology companies. The company focuses on a broad range of therapeutic areas, prioritizing those with significant growth potential and unmet medical needs. By investing in both pre-clinical and clinical stage companies, Enavate aims to improve the quality of life for patients through groundbreaking medical advancements.

Enavate Sciences collaborates with notable figures in the biotech and healthcare investment sectors, leveraging their expertise to drive impactful investments. The company's key achievements include fostering the development of pioneering therapies and technologies that address critical health challenges. Through its strategic investments, Enavate has significantly contributed to the advancement of patient care, positioning itself as a vital player in the therapeutic technology landscape.

Enavate Sciences - Similar Companies

Pathway Bioventures logo

Pathway Bioventures

curative ventures logo

curative ventures

Curie.Bio logo

Curie.Bio

curie.bio

Faze Medicines logo

Faze Medicines

fazemed.com

Bioventure Partners logo

Bioventure Partners

Axial logo

Axial

axialvc.com

Riverine Ventures logo

Riverine Ventures

riverine.ventures

Frazier Life Sciences logo

Frazier Life Sciences

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Vibe Bio logo

Vibe Bio

vibebio.com

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

ABio-X logo

ABio-X

abio-x.com

Engrail Therapeutics logo

Engrail Therapeutics

engrail.com

Enable Therapeutics logo

Enable Therapeutics

Enavate Sciences - Quick Facts

Who are Enavate Sciences' competitors?

Companies similar to Enavate Sciences include Pathway Bioventures, curative ventures, Curie.Bio and Faze Medicines.

When was Enavate Sciences founded?

Enavate Sciences was founded in 2022.

Where is Enavate Sciences' headquarters located?

Enavate Sciences' headquarters is located in New York City, NY, US.

When was Enavate Sciences' last funding round?

Enavate Sciences' most recent funding round was for $300M (USD) in May 2022.

How much has Enavate Sciences raised to-date?

As of May 2, 2022, Enavate Sciences has raised a total of $300M (USD).

How many employees does Enavate Sciences have?

Enavate Sciences has 7 employees as of Feb 4, 2024.

Enavate Sciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Technology
  • Therapeutics
Tags
  • Financial
  • Platform
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified